Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
NCT ID: NCT02523755
Last Updated: 2016-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2015-09-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to evaluate lung function and atelectasis in pregnant women with or without epidural analgesia, during labor and after delivery.
Only adult consenting patients ASA I \& ASA II (American Society of Anaesthesiologists) are included in the study. According to institutional protocols lumbal epidural catheter is inserted and tested at the start of the labor, while patients' parameters are monitored.
Refusal to epidural analgesia, technical difficulties to insert the epidural catheter or any medical contraindication will result in inclusion of these patients in the control group.
Measurement with EIT is not invasive and harmful neither for the mother nor for the child.
It consists of putting a belt around the chest; this belt is linked to a monitor which measures the impedance of the different lung regions.
Electrical impedance measurements will be done for short periods of maximum 5 min. each as follows:
1. Placement before injection of local anesthetics through the epidural catheter in the study goup; in the control subset placement of the belt will be done when an epidural anesthetic would have been considered.
2. 1 hour after placement of the belt
3. 1 hour after delivery
These periods will be compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epidural analgesia Ropivacaine
Placement of an epidural catheter to achieve pain relief
Epidural analgesia Ropivacaine
Measurement of regional distribution as assessed by EIT before and after injection of local anesthetics
Absence of epidural analgesia
Measurement of regional distribution as assessed by EIT before and after delivery
Absence of epidural analgesia
No placement of an epidural catheter either because of patient refusal or contraindication
Epidural analgesia Ropivacaine
Measurement of regional distribution as assessed by EIT before and after injection of local anesthetics
Absence of epidural analgesia
Measurement of regional distribution as assessed by EIT before and after delivery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epidural analgesia Ropivacaine
Measurement of regional distribution as assessed by EIT before and after injection of local anesthetics
Absence of epidural analgesia
Measurement of regional distribution as assessed by EIT before and after delivery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA II
Exclusion Criteria
* \< 18 years
* Expulsions
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitair Ziekenhuis Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Veerle Van Mossevelde
Data Nurse
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maxim Doutreluigne, MD
Role: PRINCIPAL_INVESTIGATOR
Universitair Ziekenhuis Brussel
Laszlo L Szegedi, Prof.
Role: STUDY_CHAIR
Universitair Ziekenhuis Brussel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis Brussel
Jette, Vlaams Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EIT
Identifier Type: -
Identifier Source: org_study_id